Literature DB >> 11956018

Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.

Sarah Boudaly1, Joëlle Morin, Rolande Berthier, Patrice Marche, Christian Boitard.   

Abstract

Nonobese diabetic (NOD) mice spontaneously develop diabetes, an auto-immune disease characterized by the destruction of insulin-secreting beta-cells by autoreactive T cells. Defects in development and/or functions of dendritic cells (DC) might be critical in eliciting the auto-immune reaction to beta cells in this model. In this paper, DC differentiation in NOD mice was investigated in vitro using bone marrow-derived progenitors (BM-DC) in the presence of GM-CSF and IL-4 or spleen-derived progenitors in the presence of GM-CSF and early acting cytokines such as Flt-3L and IL-6 (SPL-DC). In both culture systems, the absolute number of NOD DC generated was strongly reduced as compared to control strains. In addition, both BM-DC and SPL-DC from NOD mice show defective differentiation into mature DC in conventional culture conditions as indicated by low expression of MHC class II and CD80 molecules among CD11c positive cells and low capacity to stimulate allogeneic T cells. However, DC achieved full maturation when exposed to LPS, except for MHC class II expression that remained decreased. Ex vivo analysis confirmed an unusual phenotype of NOD DC. Both sets of results are thus consistent with a specific defect of DC maturation in these mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956018

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  15 in total

1.  A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.

Authors:  Jamal S Lewis; Natalia V Dolgova; Ying Zhang; Chang Qing Xia; Clive H Wasserfall; Mark A Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Clin Immunol       Date:  2015-04-02       Impact factor: 3.969

Review 2.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

3.  Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.

Authors:  Cathleen Petzold; Julia Riewaldt; Tina Koenig; Sonja Schallenberg; Karsten Kretschmer
Journal:  Rev Diabet Stud       Date:  2010-05-10

4.  Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

Authors:  Donald Cheatem; Balaji B Ganesh; Eryn Gangi; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

5.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

6.  Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.

Authors:  A C Vasquez; M Feili-Hariri; R J Tan; P A Morel
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice.

Authors:  J Morin; B Faideau; M-C Gagnerault; F Lepault; C Boitard; S Boudaly
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 8.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

9.  Reduced interferon-α production by dendritic cells in type 1 diabetes does not impair immunity to influenza virus.

Authors:  D Kreuzer; E Nikoopour; B C Y Au; O Krougly; E Lee-Chan; K L Summers; S M M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

10.  Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.

Authors:  M Jubayer Rahman; Gwendoline Rahir; Matthew B Dong; Yongge Zhao; Kameron B Rodrigues; Chie Hotta-Iwamura; Ye Chen; Alan Guerrero; Kristin V Tarbell
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.